In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
106 News Items found
mmunofluorescent light micrograph of melanoma cancer cells
In the Clinic
Noninvasive Imaging Tools Enable Better Detection of Skin Cancer

MSK dermatologists are using noninvasive imaging methods to detect skin cancer and guide its treatment.
3-D illustration (in pink) of female reproductive system anatomy
Feature
Gynecologic Cancers: The Next Immunotherapy Frontier?

Learn how immunotherapy holds promise for transforming the treatment of gynecologic cancers.
Three sets of PET images
Finding
DeepPET Uses Artificial Intelligence to Generate Images of the Body’s Internal Activities

MSK researchers are developing a new image-generation method for PET scans. It may prove to be quicker and clearer than current scans.
MSK gynecologic oncologist Carol Brown
Q&A
Q & A with Carol Brown: Clinical Trials and Cancer Disparities

MSK physician Carol Brown spoke about cancer disparities at The US State of Women Summit organized by the White House. Learn how she and MSK are leading the way in addressing this issue.
Gloved hand and magnifying glass on banded DNA sequences
Announcement
FDA Authorizes MSK-IMPACT Test for Analyzing Patient Tumors

The test, developed at MSK, looks for alterations in 468 genes that are seen in both common and rare cancers.
David Hyman and Robin Gillespie
Finding
#AACR17: Basket Trial for Experimental Drug Shows Promising Early Results

Neratinib, which targets mutations that drive cancer growth, is showing promise for treating several types of cancer.
Memorial Sloan Kettering is transforming our understanding and treatment of cancer in a myriad of ways.
Feature
Memorial Sloan Kettering Transforms Cancer Research and Care Delivery

Memorial Sloan Kettering’s vision is nothing less than to revolutionize the treatment of cancer. Learn about some of the ways we’re doing it.
Through-the-microscope view of a tissue sample
MSK Research Highlights, July 17, 2023

New MSK research identified a way to reduce toxicity in CAR T cell therapy; discovered a division of labor in DNA repair that suggests a possible therapeutic strategy for certain cancers; developed a new method to enable imaging of two PET tracers simultaneously; found biomarkers that could help predict outcomes in HER2-positive metastatic esophagogastric cancer; and made progress toward improving options for patients with early-stage, potentially indolent cancers.
(From left) David Scheinberg, Andrew Zelenetz, and Joseph Jurcic are using monoclonal antibodies to improve the treatment of patients with leukemia and lymphoma.
Monoclonal Antibody Drugs for Cancer Treatment

Therapies designed to target cancer while sparing healthy tissue show benefit, but have not yet reached full potential.
Map of world showing where postdocs came from.
International Postdocs From 60 Countries Are Training at MSK in 2025

What inspires the outstanding young scientists who come from around the world to train at MSK?